Optimization of polymyxin B in combination with doripenem to combat mutator Pseudomonas aeruginosa
Development of spontaneous mutations in Pseudomonas aeruginosa has been associated
with antibiotic failure, leading to high rates of morbidity and mortality. Our objective was to …
with antibiotic failure, leading to high rates of morbidity and mortality. Our objective was to …
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa
NS Ly, ZP Bulman, JB Bulitta… - Antimicrobial …, 2016 - pubmed.ncbi.nlm.nih.gov
Development of spontaneous mutations in Pseudomonas aeruginosa has been associated
with antibiotic failure, leading to high rates of morbidity and mortality. Our objective was to …
with antibiotic failure, leading to high rates of morbidity and mortality. Our objective was to …
Optimization of polymyxin B in combination with doripenem to combat mutator Pseudomonas aeruginosa.
NS Ly, ZP Bulman, JB Bulitta, C Baron, GG Rao… - 2016 - cabidigitallibrary.org
Abstract Development of spontaneous mutations in Pseudomonas aeruginosa has been
associated with antibiotic failure, leading to high rates of morbidity and mortality. Our …
associated with antibiotic failure, leading to high rates of morbidity and mortality. Our …
[HTML][HTML] Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa
NS Ly, ZP Bulman, JB Bulitta, C Baron… - Antimicrobial Agents …, 2016 - ncbi.nlm.nih.gov
Abstract Development of spontaneous mutations in Pseudomonas aeruginosa has been
associated with antibiotic failure, leading to high rates of morbidity and mortality. Our …
associated with antibiotic failure, leading to high rates of morbidity and mortality. Our …
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa.
NS Ly, ZP Bulman, JB Bulitta, C Baron… - Antimicrobial Agents …, 2016 - europepmc.org
Abstract Development of spontaneous mutations in Pseudomonas aeruginosa has been
associated with antibiotic failure, leading to high rates of morbidity and mortality. Our …
associated with antibiotic failure, leading to high rates of morbidity and mortality. Our …
Optimization of polymyxin B in combination with doripenem to combat mutator Pseudomonas aeruginosa
NS Ly, ZP Bulman, JB Bulitta, C Baron… - Antimicrobial …, 2016 - research.monash.edu
Abstract Development of spontaneous mutations in Pseudomonas aeruginosa has been
associated with antibiotic failure, leading to high rates of morbidity and mortality. Our …
associated with antibiotic failure, leading to high rates of morbidity and mortality. Our …
[PDF][PDF] Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa
NS Ly, ZP Bulman, JB Bulitta, C Baron, GG Rao… - 2016 - researchmgt.monash.edu
MATERIALS AND METHODS Bacterial isolates, antibiotics, susceptibility tests, and mutation
frequency. Wild-type and five isogenic strains with a deficiency in the MMR DNA repair …
frequency. Wild-type and five isogenic strains with a deficiency in the MMR DNA repair …
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa.
NS Ly, ZP Bulman, JB Bulitta, C Baron… - Antimicrobial Agents …, 2016 - europepmc.org
Abstract Development of spontaneous mutations in Pseudomonas aeruginosa has been
associated with antibiotic failure, leading to high rates of morbidity and mortality. Our …
associated with antibiotic failure, leading to high rates of morbidity and mortality. Our …